Manufacturers' promotion of off-label drug use: implications for drug safety

被引：0

作者：

Zieve, Allison ^{[1
]}

Carome, Michael A. ^{[2
]}

机构：

[1] Publ Citizen, Litigat Grp, Washington, DC 20009 USA

[2] Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA

来源：

关键词：

Drug safety; First Amendment; Food and Drug Administration; off-label promotion; AUTHORSHIP; FOOD;

D O I：

10.1080/14740338.2016.1186642

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1149 / 1151

页数：3

共 50 条

[1] Off-Label Drug Use and Promotion
Gianutsos, Gerald
[J]. US PHARMACIST, 2014, 39 (10) : 55 - 64
[2] Off-Label Drug Promotion and the Use of Disclaimers
McKenney, Dina
[J]. TEXAS LAW REVIEW, 2013, 92 (01) : 231 - 252
[3] Unlicensed and off-label drug use in children - Implications for safety
Choonara, I
Conroy, S
[J]. DRUG SAFETY, 2002, 25 (01) : 1 - 5
[4] Off-label drug promotion
不详
[J]. ONCOLOGY-NEW YORK, 1999, 13 (12): : 1616 - 1616
[5] Unlicensed and Off-Label Drug Use in ChildrenImplications for Safety
Imti Choonara
Sharon Conroy
[J]. Drug Safety, 2002, 25 : 1 - 5
[6] Off-Label Use and Safety of Drug Use in Vascular Anomalies
Kleiber, Niina
Gariepy-Assal, Laurence
Coulombe, Jerome
Marcoux, Simon
Essouri, Sandrine
McCuaig, Catherine
Powell, Julie
Soulez, Gilles
Dubois, Josee
[J]. DERMATOLOGY, 2021, 237 (04) : 649 - 657
[7] FDA is criticised for poor oversight of drug companies' promotion of off-label drug use
Tanne, Janice Hopkins
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7665):
[8] Appropriate off-label drug use
Lee, Sang Moo
[J]. JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2018, 61 (03): : 140 - 146
[9] Off-label drug use in children
Jain S.S.
Bavdekar S.B.
Gogtay N.J.
Sadawarte P.A.
[J]. The Indian Journal of Pediatrics, 2008, 75 (11) : 1133 - 1136
[10] Off-Label Drug Use in Children
Jain, Surabhi S.
Bavdekar, S. B.
Gogtay, Nithya J.
Sadawarte, Pranjali A.
[J]. INDIAN JOURNAL OF PEDIATRICS, 2008, 75 (11): : 1133 - 1136